Omontys and Lasix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omontys (peginesatide acetate) and Lasix (furosemide). Common drug interactions include deep vein thrombosis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Omontys and Lasix. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Omontys?

Omontys has active ingredients of peginesatide acetate. eHealthMe is studying from 203 Omontys users. Check the latest studies of Omontys.

What is Lasix?

Lasix has active ingredients of furosemide. It is often used in swelling. eHealthMe is studying from 210,439 Lasix users. Check the latest studies of Lasix.



On Aug, 04, 2026

11 people who take Omontys and Lasix together, and have interactions are studied.

Omontys and Lasix drug interactions.

What are the common drug interactions of Omontys and Lasix, by gender? *:

female:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Haemoglobin decreased
  3. Pallor
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Unresponsive to stimuli
  6. Abdominal discomfort
  7. Acute myocardial infarction (acute heart attack)
  8. Acute respiratory failure
  9. Aggression
  10. Anaphylactic reaction (serious allergic reaction)

What are the common drug interactions of Omontys and Lasix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal discomfort
  3. Anaphylactic reaction (serious allergic reaction)
  4. Anxiety
  5. Blood glucose increased
  6. Cardiomegaly (increased size of heart than normal)
  7. Chest pain
  8. Dizziness
  9. Electrocardiogram qt prolonged
  10. Haemoglobin decreased

50-59:

  1. Fluid overload (too much fluid in the blood)
  2. Haemoglobin decreased
  3. Acute respiratory failure
  4. Atelectasis (partial or complete collapse of the lung)
  5. Bacterial test positive
  6. Blood pressure decreased
  7. Cardiac arrest
  8. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  9. Cardiomegaly (increased size of heart than normal)
  10. Cold sweat

60+:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Acute myocardial infarction (acute heart attack)
  3. Heart rate increased
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypersensitivity
  6. Injection site pain
  7. Loss of consciousness
  8. Lung neoplasm malignant (cancer tumour of lung)
  9. Muscle spasms (muscle contraction)
  10. Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

  1. Nephrogenic Anaemia (anaemia due to kidney disease): 11 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Omontys and Lasix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omontys and Lasix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omontys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lasix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omontys and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lasix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on peginesatide acetate and furosemide (the active ingredients of Omontys and Lasix, respectively), and Omontys and Lasix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: